Class II · Moderate risk
Methohexital Sodium
Failed Impurities/Degradation Specifications
Is Methohexital recalled?
New recall announced
announced by the firm and posted by FDA; not yet in FDA’s classified recall data
-
Brevital Sodium 500 mg/vial for Injection
· Par Health ·
Reason Presence of particulate matter identified as cellulose
Yes — there is an active recall. 2 ongoing FDA recalls mention Methohexital (4 total). Check the affected lots below.
Most common reason: Impurity / degradation (2 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Methohexital. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Methohexital recalls in 2026
2 initiated in 2026, 4 in total — newest first
Class II · Moderate risk
Methohexital Sodium for Injection
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Methohexital Sodium all strengths
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Class II · Moderate risk
Methohexital
Lack of Assurance of Sterility
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.